181 related articles for article (PubMed ID: 36113064)
21. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
[TBL] [Abstract][Full Text] [Related]
22. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
[TBL] [Abstract][Full Text] [Related]
23. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
[TBL] [Abstract][Full Text] [Related]
24. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.
Middleton MS; Van Natta ML; Heba ER; Alazraki A; Trout AT; Masand P; Brunt EM; Kleiner DE; Doo E; Tonascia J; Lavine JE; Shen W; Hamilton G; Schwimmer JB; Sirlin CB;
Hepatology; 2018 Mar; 67(3):858-872. PubMed ID: 29028128
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease.
Torkzaban M; Wessner CE; Halegoua-DeMarzio D; Rodgers SK; Lyshchik A; Nam K
Acad Radiol; 2023 Sep; 30(9):1838-1845. PubMed ID: 36586759
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
[TBL] [Abstract][Full Text] [Related]
28. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
[TBL] [Abstract][Full Text] [Related]
29. Interobserver Variability in Ultrasound-Based Liver Fat Quantification.
Şendur HN; Cerit MN; Ibrahimkhanli N; Şendur AB; Özhan Oktar S
J Ultrasound Med; 2023 Apr; 42(4):833-841. PubMed ID: 35778902
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
Cassinotto C; Jacq T; Anselme S; Ursic-Bedoya J; Blanc P; Faure S; Belgour A; Guiu B
Radiology; 2022 Nov; 305(2):353-361. PubMed ID: 35819322
[TBL] [Abstract][Full Text] [Related]
31. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
Beyer C; Hutton C; Andersson A; Imajo K; Nakajima A; Kiker D; Banerjee R; Dennis A
PLoS One; 2021; 16(4):e0249491. PubMed ID: 33793651
[TBL] [Abstract][Full Text] [Related]
32. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
[TBL] [Abstract][Full Text] [Related]
33. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
[TBL] [Abstract][Full Text] [Related]
34. Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosis.
Li X; Sun Z; Liu W; Sun L; Ren J; Xu Y; Yu H; Bai W
Heliyon; 2024 Jun; 10(11):e31904. PubMed ID: 38845969
[TBL] [Abstract][Full Text] [Related]
35. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
Kang KA; Lee SR; Jun DW; Do IG; Kim MS
Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.
Wang JH; Ou HY; Yen YH; Hung CH; Lu SN
Liver Int; 2023 Sep; 43(9):1901-1908. PubMed ID: 37249034
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
39. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
Dillman JR; Thapaliya S; Tkach JA; Trout AT
AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
[No Abstract] [Full Text] [Related]
40. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
Park S; Kwon JH; Kim SY; Kang JH; Chung JI; Jang JK; Jang HY; Shim JH; Lee SS; Kim KW; Song GW
Korean J Radiol; 2022 Dec; 23(12):1260-1268. PubMed ID: 36447414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
